This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanjing Ruijie Pharmatech Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Peipei Wang: Innovator in ACC Inhibitors
Introduction
Peipei Wang is a notable inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that serve as ACC inhibitors. Her work is aimed at addressing diseases mediated by ACC, showcasing her commitment to advancing medical research.
Latest Patents
Peipei Wang holds a patent for "Compounds and their uses as ACC inhibitors." This invention provides compounds of Formula (I) that can be utilized as ACC inhibitors and serve as potent therapeutic agents against various diseases. The patent highlights her innovative approach to tackling complex health issues.
Career Highlights
Wang is currently associated with Nanjing Ruijie Pharmatech Co., Ltd., where she continues to engage in groundbreaking research. Her role in the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovation.
Collaborations
Peipei Wang has worked alongside esteemed colleagues such as Junbo Zhang and Hong Liao. These collaborations have fostered a dynamic research environment, enabling the team to explore new avenues in drug development.
Conclusion
Peipei Wang's work in developing ACC inhibitors exemplifies her dedication to improving healthcare through innovation. Her contributions are vital in the ongoing quest for effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile